Hôpital Wansiri
| Thaïlande | Turquie | Espagne | |
| Thérapie à l'actinium-225 | de $25,000 / 925,000฿ | de $22,955 / 849,335฿ | de $45,000 / 1,665,000฿ |
| Microchirurgie de Mohs | de $2,200 / 81,400฿ | de $2,200 / 81,400฿ | de $2,200 / 81,400฿ |
| Immunothérapie avec Keytruda (Pembolizumab) | de $8,000 / 296,000฿ | de $3,300 / 122,100฿ | de $15,000 / 555,000฿ |
| Chirurgie du mélanome | de $4,000 / 148,000฿ | de $3,500 / 129,500฿ | de $4,500 / 166,500฿ |
| Thérapie topique du mélanome | - | de $1,450 / 53,650฿ | de $6,285 / 232,545฿ |
Dr. Ohm Sudchumphae is a regenerative medicine specialist at Panacee Hospital Rama 2 in Bangkok. He holds a Master’s in Clinical Nutrition and Integrative Medicine. Dr. Ohm is currently pursuing a Doctorate in Psychology. He specializes in combining cell therapy, IV nutrition, and medicinal herbology for chronic conditions.
Le traitement du mélanome en Thaïlande comprend l'excision locale large, la chirurgie de Mohs et la biopsie du ganglion sentinelle. Les centres internationaux proposent une immunothérapie avancée utilisant des inhibiteurs de PD-1 comme le Keytruda. Des thérapies ciblées pour les mutations BRAF et des options basées sur les cellules, comme la thérapie par cellules NK, sont également disponibles. La plupart des hôpitaux détiennent l'accréditation JCI.
Avis d'expert Bookimed : L'infrastructure thaïlandaise permet des transitions rapides entre le diagnostic et le traitement. La plupart des cliniques accréditées JCI à Bangkok effectuent les tests moléculaires et la stadification en moins de 48 heures. Cette rapidité est vitale pour les cas de mélanome agressif. Certains centres se spécialisent également dans la combinaison de protocoles standard avec des thérapies régénératives par cellules NK.
Consensus des patients : Les patients soulignent la rapidité des résultats diagnostiques par rapport à leur pays d'origine. Beaucoup apprécient les explications approfondies fournies par les oncologues concernant les effets secondaires de l'immunothérapie.
Les hôpitaux thaïlandais recommandés pour le mélanome incluent Bumrungrad International et le Bangkok Hospital. Ces établissements détiennent l'accréditation de la Joint Commission International pour la qualité. Ils utilisent des outils de diagnostic avancés comme les scanners PET-CT. Des centres spécialisés comme le Wattanosoth Cancer Hospital se concentrent entièrement sur la recherche et les soins en oncologie.
Avis d'expert Bookimed : Les centres d'oncologie thaïlandais abritent souvent des sous-centres spécialisés pour le cancer de la peau. Bumrungrad, par exemple, exploite le Horizon Regional Cancer Center. Cette concentration dédiée conduit à des volumes de patients plus élevés. Les médecins y acquièrent plus d'expérience avec les stades complexes de mélanome. Choisir ces unités spécialisées garantit l'accès à des conseils multidisciplinaires sur les tumeurs.
Consensus des patients : Les patients mentionnent souvent que le personnel et les médecins sont très professionnels. Ils notent que les installations sont propres et modernes. Beaucoup apprécient la rapidité des tests de diagnostic dans les hôpitaux de Bangkok. L'attention personnelle des infirmières ressort également dans leurs avis.
La convalescence après une chirurgie du mélanome en Thaïlande prend généralement 1 à 3 semaines pour la cicatrisation primaire. La plupart des patients peuvent rentrer chez eux en toute sécurité 7 à 10 jours après l'opération. Les voyages long-courriers nécessitent souvent d'attendre au moins 14 jours pour minimiser les risques de caillots sanguins. Votre chirurgien doit vous fournir un certificat d'aptitude au vol.
Avis de l'expert Bookimed : Les centres d'oncologie thaïlandais comme Bumrungrad ou le Bangkok Hospital coordonnent souvent des examens pluridisciplinaires en 48 heures. Cette efficacité aide les patients internationaux à commencer leur convalescence plus rapidement. Nos données montrent que les centres à fort volume privilégient la mobilité précoce pour les voyageurs. Cette approche permet de maintenir un taux de 95 % de départs sans complications.
Consensus des patients : Les patients soulignent qu'il est essentiel de rester près de la clinique pendant la première semaine. Ils insistent souvent sur le fait que la gestion des gonflements est le plus grand défi pendant le vol de retour.
Melanoma treatment in Thailand includes surgical excision, immunotherapy with PD-1 inhibitors like Keytruda, and Mohs microsurgery. JCI-accredited hospitals in Bangkok provide these therapies. They also offer Natural Killer (NK) cell therapy and targeted radiopharmaceutical treatments. Centres like Bumrungrad International Hospital often complete staging and molecular testing within 48 hours.
Bookimed Expert Insight: Many Australian patients seek standard surgery, but Thailand offers integrated care. Bumrungrad International Hospital treats over 1,000,000 patients annually. It maintains GHA and JCI accreditations. This high volume allows clinics to offer niche treatments like Natural Killer cell therapy. This combination is rare in smaller regional centres and helps with complex cases.
Patient Consensus: Patients note that prompt specialist assessment and accurate pathology reviews are vital. They highlight the importance of multidisciplinary teams. It is also important to have clear follow-up plans for when they return home.
Specialised immunotherapy and targeted melanoma treatments are widely available in Thailand. Leading Bangkok hospitals offer options like Keytruda and BRAF mutation testing. These facilities maintain high standards through JCI and ISO certifications. This means patients receive care comparable to Australian private hospitals.
Bookimed Expert Insight: While many centres treat general oncology, Bumrungrad International Hospital manages over 1,000,000 patients annually. This massive volume includes international patients from 190 countries. Their experience with complex foreign cases often means smoother logistics for Australians. This includes easier access to English-speaking specialists and streamlined medical records.
Patient Consensus: Patients note that Thailand provides faster access to treatment than many public systems. They suggest confirming specific drug stock and mutation testing availability before flying to Bangkok.
Mohs micrographic surgery is available in Thailand at specialised tertiary hospitals and cancer centres. Fellowship-trained surgeons perform this precise procedure. It reports success rates of 97% to 99%. It remains a primary choice for high-risk melanoma and delicate areas like the face.
Bookimed Expert Insight: Thailand ranks 4th globally for international patient requests in our database. Major hospitals like Bumrungrad International serve 190 countries and prioritise digital health records. This infrastructure helps Australian patients receive seamless follow-up care with their local GP.
Patient Consensus: Patients note it is important to confirm if a clinic uses frozen-section Mohs or staged excision. They suggest getting a written plan covering margin control and pathology before travelling to Thailand.
Melanoma treatment in Thailand typically begins within a few days to two weeks of diagnosis. Hospitals like Bumrungrad International provide molecular testing and staging within 48 hours. This efficiency allows surgeons and oncologists to finalise treatment plans and schedule theatre time almost immediately.
Bookimed Expert Insight: Thailand leads in rapid oncology onboarding. Major centres like Bumrungrad International have 1,300 doctors on-site. This scale eliminates the long waiting lists common in Australia. Patients can often start immunotherapy or surgery in under 5 days if pathology slides are ready.
Patient Consensus: Patients note that bringing original pathology slides and imaging reports from Australia speeds up the process. Same-day specialist consults in Bangkok are common. However, hospitals often require upfront deposits before booking surgery or targeted therapies.
Patients can get a second opinion for melanoma in Thailand at JCI-accredited centres. Specialists offer expert reviews of pathology slides, BRAF gene testing, and staging. Many clinics provide remote consultations. This allows Australians to access oncology expertise and immunotherapy protocols before travelling for treatment.
Bookimed Expert Insight: Thailand ranks 4th globally for patient requests. Bumrungrad International Hospital alone serves 1,000,000 patients annually. This massive volume means Thai oncologists see many advanced melanoma cases. For Australians, this scale helps build expertise in rare or resistant melanoma subtypes.
Patient Consensus: Patients note it is important to request a review of both diagnosis and staging. They recommend bringing pathology slides to Thailand for an independent assessment by a surgical oncologist.
Thailand serves over 1 million international patients annually with melanoma care through JCI-accredited hospitals. Specialist centres provide multidisciplinary treatment including Mohs microsurgery and PET-CT diagnostics. They also offer modern immunotherapies like Keytruda. These facilities use tumour boards to coordinate surgical oncology and pathology services for precise results.
Bookimed Expert Insight: Many Australian patients focus only on major surgical hubs. However, integrative centres like Panacee Hospital Rama 2 offer alternative supportive therapies. These include Oncothermia and cell-based treatments. Combining these with surgery at major Bangkok facilities creates a comprehensive recovery plan. This dual approach helps manage complex stages that standard protocols might not address alone.
Patient Consensus: Patients find it essential to choose hospitals with dedicated oncology teams. They advise against using cosmetic dermatology clinics for melanoma care. Experience shows that checking for in-house histopathology review is vital. Patients also suggest checking that imaging can be sent to Australia for follow-up.
